lysophosphatidic acid has been researched along with Endometrial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdalla, W; Ariztia, EV; Fishman, DA; Hope, JM; Long, K; Wang, FQ; Whyte, JS | 1 |
| Ariztia, EV; Boyd, LR; Fishman, DA; Hetherington, JA; Horton, FR; Smicun, Y; Smith, PJ; Wang, FQ | 1 |
2 other study(ies) available for lysophosphatidic acid and Endometrial Neoplasms
| Article | Year |
|---|---|
LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
Topics: Cell Adhesion; Cell Communication; Cell Line, Tumor; Endometrial Neoplasms; Enzyme Activation; Extracellular Matrix; Female; Gene Silencing; Humans; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 7; Neoplasm Invasiveness; Receptors, Lysophosphatidic Acid; RNA, Small Interfering; Transfection | 2009 |
Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
Topics: Carcinoma, Endometrioid; Cell Growth Processes; Cell Line, Tumor; Endometrial Neoplasms; Enzyme Activation; Female; Fibrosarcoma; Humans; Lysophospholipids; Matrix Metalloproteinase 2; Matrix Metalloproteinase 7; Matrix Metalloproteinases; Neoplasm Invasiveness; RNA, Messenger | 2010 |